BioSpace News Archive

Komodo Health today announced a collaboration with Karyopharm Therapeutics Inc. (Nasdaq: KPTI) to accelerate clinical trial recruitment and site identification in an effort to speed patient access to a potential new treatment for COVID-19.

Abbott (NYSE: ABT) announced today that the FreeStyle Libre 14 day system, the world’s leading3 continuous glucose monitoring (CGM) technology, can now be used in the hospital setting2 during the COVID-19 pandemic, according to the U.S. Food and Drug Administration (FDA)

MDimune, Inc., a cell-derived vesicle (CDV)-based therapeutics company, announced on March 18th of this year that the Company has been granted a key patent pertaining to its proprietary BioDrone® technology by the United States Patent and Trademark Office.

As life-saving ventilators grow scarcer worldwide in the fight against COVID-19, an Auburn University research team is racing against the clock to get a device they’ve built into mass production.

As government and private institutions race to develop an effective cure for patients infected by COVID-19, two antimalarial drugs--chloroquine and hydroxychloroquine--have shown some possible potential.

AbbVie, a global research and development-based biopharmaceutical company, today announced that the AbbVie CF Scholarship program is now accepting applications for the 2020-2021 academic school year.

Companion Medical, manufacturer of InPen, the FDA-cleared intelligent insulin system for people with diabetes who practice multiple daily injections, today announced the launch of the new version of the InPen app.

Littelfuse, Inc. (NASDAQ: LFUS), a global manufacturer of leading technologies in circuit protection, power control and sensing, announced today that it will release financial results for its first quarter of fiscal 2020 prior to market open on Wednesday, April 29, 2020.

A new prognostic tool predicts how long someone diagnosed with chronic lymphocytic leukemia (CLL) will be able to wait before starting cancer treatment.

BIOLASE, Inc., a leader in medical devices, today announced that it expects to join the fight against the coronavirus (COVID-19) outbreak by teaming up with MEKICS Co. Ltd, an intensive care unit (ICU) equipment manufacturer, to supply MEKICS’s MTV-1000 ICU-grade portable ventilator through BIOLASE’s FDA-registered manufacturing facility in California.